305 companies spend more than 10percent of their revenue on R & D, and 100 companies spend more than 100 million on R & D

category:Finance
 305 companies spend more than 10percent of their revenue on R & D, and 100 companies spend more than 100 million on R & D


The reporter further combed and found that during the reporting period, the R & D expenses of 18 companies, including Caesar culture, Sihuan biology, Tianjin CikA, Kangchen pharmaceutical, North Huachuang, Dongfang Guoxin, Bo Chuang technology, nevei technology, Xunyou technology, Shenzhou Taiyue, Datang Telecom, Jiudian pharmaceutical, Lanxin technology, precise measurement electronics, chenan technology, pilot intelligence, Shennong technology, Jintuo Co., Ltd., achieved year-on-year results Increase by 100% or more. The R & D investment cost of 36 companies in the reporting period, including xinlitai, sunyuan, train control, guanghetong, Yaoshi technology, Zhaoyi innovation, Huina technology, iFLYTEK, Zhongshan Jinma, zhonghaida, Yuxin technology, Rongji software, has increased by more than 50% year on year.

Under the background that the recent market continues to shake and bottoms, it is a stable strategy for investors to make investment layout according to the rating performance of individual stocks of securities companies. Among the 305 stocks mentioned above, 14 stocks, such as Weining health, Hengsheng electronics, leading intelligence, Hikvision, Qiming star, Hengrui medicine, aerospace appliances, Zhongxin Saike, iFLYTEK, perfect world, Shenxin, Shengbang Co., Ltd., gibbit and Zhongke Chuangda, have been jointly recommended by 15 or more institutions in the past 30 days, and the future performance is worthy of close tracking. As for Weining health, which has the highest number of rating agencies, Huaxin Securities said that as a leading domestic medical information enterprise, it actively arranged the field of medical and health services, deeply implemented the 4 + 1 development strategy, and constantly promoted the coordinated development of cloud medicine, cloud medicine, cloud insurance, cloud health and innovative service platform. Under the background of favorable national policies, the market space of medical information is expanding, and the companys development prospects are optimistic. Source: responsible editor of Securities Daily: Yang bin_nf4368

Under the background that the recent market continues to shake and bottoms, it is a stable strategy for investors to make investment layout according to the rating performance of individual stocks of securities companies. Among the 305 stocks mentioned above, 14 stocks, such as Weining health, Hengsheng electronics, leading intelligence, Hikvision, Qiming star, Hengrui medicine, aerospace appliances, Zhongxin Saike, iFLYTEK, perfect world, Shenxin, Shengbang Co., Ltd., gibbit and Zhongke Chuangda, have been jointly recommended by 15 or more institutions in the past 30 days, and the future performance is worthy of close tracking.

As for Weining health, which has the highest number of rating agencies, Huaxin Securities said that as a leading domestic medical information enterprise, it actively arranged the field of medical and health services, deeply implemented the 4 + 1 development strategy, and constantly promoted the coordinated development of cloud medicine, cloud medicine, cloud insurance, cloud health and innovative service platform. Under the background of favorable national policies, the market space of medical information is expanding, and the companys development prospects are optimistic.